IRC
QTTB icon

Investors Research Corp’s Q32 Bio QTTB Stock Holding History

Investors Research Corp’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9
Closed -$97 – 1100
2023
Q4 		$97 Hold
9
– – ﹤0.01% 1043
2023
Q3 		$187 Hold
9
– – ﹤0.01% 1045
2023
Q2 		$142 Hold
9
– – ﹤0.01% 1062
2023
Q1 		$165 Hold
9
– – ﹤0.01% 1095
2022
Q4 		$202 Hold
9
– – ﹤0.01% 1109
2022
Q3 		$0 Hold
9
– – ﹤0.01% 1142
2022
Q2 		$0 Hold
9
– – ﹤0.01% 1160
2022
Q1 		$0 Hold
9
– – ﹤0.01% 1104
2021
Q4 		$1K Hold
9
– – ﹤0.01% 964
2021
Q3 		$1K Hold
9
– – ﹤0.01% 971
2021
Q2 		$1K Hold
9
– – ﹤0.01% 955
2021
Q1 		$2K Hold
9
– – ﹤0.01% 909
2020
Q4 		$2K Hold
9
– – ﹤0.01% 1008
2020
Q3 		$2K Buy
+9
New +$2.02K ﹤0.01% 1011

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Investors Research Corp's QTTB Position: Q1 2024 in Review

Investors Research Corp sold out of Q32 Bio (QTTB) in Q1 2024, closing a stake of 9 shares — an estimated $97 sold.

Investors Research Corp first reported a position in QTTB in Q3 2020 and held it in 14 quarters. The position peaked at $2K in Q1 2021. 39 funds tracked by Wall St. Rank hold QTTB as of Q1 2024.

  • Investors Research Corp reported no remaining Q32 Bio position as of Q1 2024 after selling out during the quarter.
  • Investors Research Corp sold 9 Q32 Bio shares in Q1 2024, an estimated $97.
  • Investors Research Corp first reported a position in Q32 Bio in Q3 2020 and held it in 14 quarters.
  • Investors Research Corp's Q32 Bio position peaked at $2K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2024.

Based on Investors Research Corp's 13F filing for Q1 2024, filed 6 May 2024.